BD Hypodermic Syringe 10 ml, eccentric tip. Catalog (Ref No.) 305482

FDA Device Recall #Z-1109-2021 - Class II, December 23, 2020

Recall Summary

Recall Number Z-1109-2021
Classification Class II - Moderate risk
Date Initiated December 23, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Becton Dickinson & Company
Location Franklin Lakes, NJ
Product Type Devices
Quantity 155,200 needles

Product Description

BD Hypodermic Syringe 10 ml, eccentric tip. Catalog (Ref No.) 305482

Reason for Recall

The product packaging for the 10 ml eccentric tip syringe may exhibit open seals. An open seal impacts package integrity and potentially compromises sterility of the syringe.

Distribution Pattern

Distribution US nationwide and Canada

Lot / Code Information

Catalog (Ref No.) 305482 100/package UDI 00382903054824 Lot # 8142303 exp date 31-May-2023

Other Recalls from Becton Dickinson & Company

Recall # Classification Product Date
Z-2257-2026 Class I BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3... Apr 27, 2026
Z-2249-2026 Class I BD¿Spinal Tray with BD¿Quincke Needle 25 G x 3.... Apr 27, 2026
Z-2251-2026 Class I BD¿Spinal Tray with BD¿Whitacre Needle 22 G x 3... Apr 27, 2026
Z-2255-2026 Class I BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3... Apr 27, 2026
Z-2256-2026 Class I BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3... Apr 27, 2026

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately, you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.